First report of emicizumab use in a female patient with severe hemophilia A.Verstraete, Géraldine;Lambert, Catherine;Hermans, Cédric(2020) Blood Advances — Vol. 4, n° 13, p. 2950-2952 (2020)
Files2020_Verstraete_Blood_Adv.pdf Open Access Adobe PDF595.47 KBDownloadDetailsAuthorsVerstraete, GéraldineUCLouvainAuthorLambert, CatherineUCLouvainAuthorHermans, CédricUCLouvainAuthorAbstractKEY POINTS : This is the first report of successful use of emicizumab in a female patient with severe hemophilia A.Show moreAffiliationsUCLouvainSSS/IREC/CARD - Pôle de recherche cardiovasculaireUCLouvainSSS/IREC/SLUC - Pôle St.-LucUCLouvain(SLuc) Service d'hématologieShow moreCitations APA Chicago FWB Verstraete, G., Lambert, C., & Hermans, C. (2020). First report of emicizumab use in a female patient with severe hemophilia A. Blood Advances, 4(13), 2950-2952. https://doi.org/10.1182/bloodadvances.2020002364 (Original work published 2020)